50 percent of patients hospitalized with COVID-19 and 19 percent of asymptomatic patients had at least one post-COVID-19 condition

Wide variation seen in continuity of nursing staff for home health care visits to dementia patients following hospitalization

However, opioids still commonly dispensed, with high-risk prescribing practices suspected in young children

Increased in-hospital mortality for COVID-19 patients with schizophrenia versus those without severe mental illness

Donanemab has already received a 'breakthrough therapy' designation from the FDA